Sales will be best they have had
$Evogene (EVGN.US)$ should beat ER since this is its first year to have sales from its Lavie Bio section in the spring wheat season. They fully sold out of their Bio-inoculant result product and will increase production for next season.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
fionaa : may i ask how redbox
Mcsnacks H Tupack OP fionaa : Whenever they combine as a company people are going to get seriously screwed over. And they wont say when it will be. One day they will look and the stock will be at .87c. Too much risk for me. But people were buying $Genocea Biosciences (GNCA.US)$ and they declared bankruptcy and that they were delisting. And the stock went up 80%.
Mcsnacks H Tupack OP Harry Ang : I got my buy set at .94 for the next hour then I’ll move it up to .96.
Mcsnacks H Tupack OP Harry Ang : Last time they reported ER volume was 3 million. And it made a 39% run up and they missed ER.
Mcsnacks H Tupack OP Harry Ang : And it’s a bust. Out at .96.
Revelation 6 : This company has no bank debt.